Avalyn Appoints Industry Veterans Jill Denning and Kimberley Cummings to Leadership
Appointments expand clinical and regulatory capabilities ahead of key program milestonesBOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc.,...
Pharmaceutical
ORYZON Strengthens Patent Portfolio for iadademstat with European Grant Decision Covering Combinations with PD1/PD-L1 Inhibitors
MADRID and CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical...
PharmaTher Announces Sale of Ketamine ANDA with Potential to Generate Over US$25 Million in Milestone and Profit-Sharing Payments
TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a specialty...
CRISPR Therapeutics to Present Preclinical Data on Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Gene Editing Technology at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress
ZUG, Switzerland and BOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating...
COUR Pharma Secures FDA Orphan Drug Designation for CNP-106 in Generalized Myasthenia Gravis
CHICAGO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, antigen-specific immune tolerance therapies for...
Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee (DSMC) to Accelerate 177Lu-RAD202 Phase 1 ‘HEAT’ Dose Escalation Clinical Trial
Phase 1 study to progress to the next dose level of 75mCi in patients with HER2+ advanced solid tumors, instead...
AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19
- Meeting date aligns with prior guidance - - FDA to review AEON’s analytical development plan and initial data -...
Quintessence Psychiatry Adopts Mentavi’s Mental Health Diagnostic Evaluation to Offer More Rigorous, Timely ADHD Assessments in Private Practice
Early Patient Feedback Points to Clearer Understanding of Results and Smoother Treatment Planning GRAND RAPIDS, MICHIGAN / ACCESS Newswire /...
11th Annual ISS National Lab and NSF Announce Funding Opportunity for Physical Science Research on Space Station
Also, six new projects from previous NSF/CASIS joint solicitations were selected to advance tissue engineering and transport phenomena research through...
Precision Biologics Manufacturing Launches Advanced Biologics Facility
Precision Biologics Manufacturing breaks ground creating 200-300 jobs and expanding U.S.-based wound care manufacturing in 2026 HENDERSON, NV AND LAS...
Liberty HealthShare Releases Comprehensive White Paper Marking 30 Years of Healthcare Sharing Ministry Innovation
White Paper Documents 30-Year Journey from Church Aid Plan to National Ministry CANTON, OH / ACCESS Newswire / September 30,...
ARTEMIS ANNOUNCES ACQUISITION OF MILLROCK TECHNOLOGY
KINGSTON, N.Y., Sept. 30, 2025 /PRNewswire/ -- Artemis Capital Partners ("Artemis"), a Boston-based private equity firm focused exclusively on partnering...
DataJoint Closes $4.9M Seed Funding to Revolutionize Data Management and AI in Academic and Life Sciences /Pharma
BARCELONA, Spain and SALT LAKE CITY and AUSTIN, Texas, Sept. 30, 2025 /PRNewswire/ -- DataJoint, a leading computational database and...
ISPE Announces its 2025 ISPE Pharma 4.0™ Conference Keynote Speakers and Tracks
The 2025 ISPE Pharma 4.0™ Conference, focused on enabling effective digital transformation in operations, will take place from 9–10 December...
Cardinal Health to expand pharmaceutical distribution network with new Indianapolis facility
DUBLIN, Ohio, Sept. 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced plans for a new flagship forward distribution...
Briya Partners with Tanner Health to Develop New Pathways for Clinicians and Researchers to Access Meaningful Insights, Accelerating Clinical Innovation and Improving Patient Care in Southern U.S.
Partnership will Combine Briya's Proprietary AI Platform with Tanner's Robust Patient Network to Drive Transformative Research NEW YORK, Sept. 30,...
Beyond 3+3: Rethinking Early-Phase Oncology Study Design, Upcoming Webinar Hosted by Xtalks
In this free webinar, understand why traditional 3+3 dose escalation designs are increasingly unsuitable for modern oncology drug development. Attendees...
From Research to GMP-Ready Cell Lines: Bridging the Development Gap, Upcoming Webinar Hosted by Xtalks
In this free webinar, gain insight into strategies for bridging the gap from research to GMP-compliant manufacturing. Attendees will learn...
Moving the Needle in Vaccine Trials: Optimizing Digital Endpoint and Operational Strategies to Enable Study Success, Upcoming Webinar Hosted by Xtalks
In this free webinar, gain insight into applying FDA and EMA safety and toxicity grading guidance to keep eCOA data...
DeepIntent Expands HealthFirst™ Media Suite with Audio Package, Connecting Healthcare Brands to Trusted Streaming Publishers
NEW YORK, Sept. 30, 2025 /PRNewswire/ -- DeepIntent, the leading healthcare demand-side platform, today unveiled its HealthFirst™ Audio Package, offering healthcare...